CD19 or CD20 CAR T Cell Therapy Demonstrates Durable Antitumor Efficacy in Patients with Central Nervous System Lymphoma
In: Human gene therapy, Jg. 33 (2022), Heft 5/6, S. 318-329
serialPeriodical
Zugriff:
Titel: |
CD19 or CD20 CAR T Cell Therapy Demonstrates Durable Antitumor Efficacy in Patients with Central Nervous System Lymphoma
|
---|---|
Autor/in / Beteiligte Person: | Liu, Rui ; Cheng, Qian ; Kang, Liqing ; Wang, Erhua ; Li, Ying ; Zhang, Jian ; Xiao, Han ; Zhang, Yi ; Chu, Ling ; Chen, Xin ; Zhang, Chang ; Tan, Jingwen ; Xu, Nan ; Li, Minghao ; Yu, Lei ; Li, Xin |
Link: | |
Zeitschrift: | Human gene therapy, Jg. 33 (2022), Heft 5/6, S. 318-329 |
Veröffentlichung: | 2022 |
Medientyp: | serialPeriodical |
ISSN: | 1043-0342 (print) |
Sonstiges: |
|